San Diego – Scripps Translational Science Institute (STSI) will present its third annual educational conference exploring the latest achievements and challenges in the field of genomics March 5-6, 2010 in San Diego.
The conference, “The Future of Genomic Medicine III”, will offer a dynamic, interactive forum where human geneticists, genomic scientists, physicians and health care professionals of all disciplines can gain valuable insights from many of the nation’s leading genomics experts.
Presenting this year’s keynote address will be Dr. Leroy Hood, one of the world’s leading scientists in molecular biotechnology and genomics. Dr. Hood’s many accolades include the 2002 Kyoto Prize for Advanced Technology and the 2003 Lemelson-MIT Prize for inventing instruments that have helped decode the human genome.
A special introductory lecture on the future of genomic medicine will be delivered by Life Technologies Chairman and CEO Gregory T. Lucier.
The program will include a series of 28 specialized presentations, interspersed with panel discussions and question-and-answer sessions. The March 5 sessions will focus on the whole genomic sequencing of people. Presentations on March 6 will cover a wide range of topics, such as cancer genomics, genomics of healthy aging and pharmacogenomics.
The conference is led by course co-directors Eric J. Topol, M.D. of STSI and Scripps Health and Robert L. Strausberg, Ph.D. of the Ludwig Institute. The program will take place at The Neurosciences Institute Auditorium, located at 10640 John Jay Hopkins Dr., San Diego, Calif., 92121.
Registration for the conference is $80 and is complimentary for all students, residents and fellows. Pre-registration will be accepted through Feb. 26, 2010 on a space-available basis.
Part of San Diego, Calif.-based Scripps Health, the Scripps Translational Science Institute (STSI) is a unique community collaboration that initiates research that moves basic science from the lab to the patient bedside. STSI is supported by the NIH flagship program, Clinical and Translational Science Award (CTSA).
Collaborators in the STSI consortium include Scripps Health; The Scripps Research Institute; the Burnham Institute for Medical Research; Children’s Hospital of Philadelphia; Genomics Institute of the Novartis Research Foundation; The J. Craig Venter Institute; Salk Institute for Biological Studies; San Diego State University; San Diego Supercomputer Center; and The Neurosciences Institute.